BioXcel Therapeutics
BTAI
BTAI
116 hedge funds and large institutions have $475M invested in BioXcel Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
16% less capital invested
Capital invested by funds: $567M → $475M (-$92M)
Holders
116
Holding in Top 10
–
Calls
$11.3M
Puts
$10.5M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$9.83M | |
| 3 | +$6.66M | |
| 4 |
Two Sigma Investments
New York
|
+$6.45M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$5.63M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$29.2M | |
| 3 | -$25.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$17.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.15M |